State of Maharashtra, India

Nitin Bhalachandra Dharmadhikari

This inventor holds 26 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 6 EPO patents, primarily in Oral Drug Delivery. Top assignees: Sun Pharma Advanced Research Company Limited, Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Advanced Research Centre Limited. Active years: 2003-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nitin Bhalachandra Dharmadhikari. Retrieved from https://idiyas.com/inventor/nitin-bhalachandra-dharmadhikari

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 

% Patents Active = 61.5


 

Average Co-Inventor Count = 2.8

ph-index = 5

Forward Citations = 147(Granted Patents)


Location History:

  • State of Maharashtra, IN (2019)
  • Maharashtra, IN (2003 - 2022)
  • Mumbai, IN (2010 - 2022)

Company Filing History:


Years Active: 2003-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Oral Drug Delivery
Pharmaceutical Composition
Gastric Retention
Abuse Deterrent
Controlled Release
Stable Composition
Spaced Drug Delivery
Fingolimod
Capsule Cutting Device
Solid Dosage Form
Spasticity Treatment
26 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Nitin Bhalachandra Dharmadhikari

Introduction

Nitin Bhalachandra Dharmadhikari is a prominent inventor from the State of Maharashtra, India. With a remarkable achievement of 26 patents to his name, he has significantly contributed to the field of pharmaceutical innovations.

Latest Patents

Nitin's latest inventions include two notable patents. The first is an "Amorphous dispersion of 4-methyl-3-quinolin-3-ylethynyl-benzoic acid n'-(2-chloro-6-methyl-benzoyl) hydrazide," which describes an oral solid dosage form comprising a mixture of a specified compound and a fusible polymeric carrier, along with optionally pharmaceutically acceptable excipients, where the mixture is an amorphous dispersion. The second patent is titled "Abuse deterrent oral solid dosage form," focusing on a formulation designed to deter misuse through its innovative composition.

Career Highlights

Throughout his career, Nitin has worked with esteemed organizations, including Sun Pharma Advanced Research Company Limited and Sun Pharmaceutical Industries Limited. His role in these companies has enabled him to push the boundaries of pharmaceutical research and development, paving the way for innovative solutions to complex health challenges.

Collaborations

Nitin has collaborated with talented professionals such as Yashoraj Rupsinh Zala and Dilip Shanghvi. Their joint efforts on various projects have undoubtedly enriched the pharmaceutical industry, resulting in groundbreaking advancements.

Conclusion

In summary, Nitin Bhalachandra Dharmadhikari's contributions to the field of pharmaceuticals through his inventions and patents demonstrate his commitment to innovation. His work not only enhances drug formulations but also addresses significant concerns related to drug abuse, making him a noteworthy figure in today’s pharmaceutical landscape.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…